Dr Zoe Williams, a television doctor known for her work on "This Morning," recently experienced a serious heart health episode while on holiday in Spain, an incident that has heightened her awareness of cardiovascular risks and the importance of ongoing research funded by the British Heart Foundation (BHF).
During a weekend trip with friends, Williams was taken to a Spanish hospital after experiencing an unusually rapid heart rate while swimming. Initially, she noticed her heart beating extremely fast but was unable to get an accurate pulse. Later that day, as her symptoms persisted, paramedics were called, and monitors revealed her heart rate fluctuating dangerously between 150 and 300 beats per minute, well beyond the typical range.
Doctors diagnosed her with atrial flutter, a heart rhythm disorder characterized by rapid atrial contractions. Williams was administered medication to control her heart rate, but when it spiked to over 300 beats per minute, medical staff performed a cardioversion—a procedure delivering low-energy electrical shocks to restore a normal heart rhythm. The treatment temporarily reduced her heart rate to 150, after which she continued to be monitored until the arrival of a cardiologist.
Williams recounted the emotional impact of the situation, noting the gravity of her condition despite attempts to maintain humor with friends. The following day, her heart rate had stabilized to its normal level of around 60 beats per minute, allowing her to return to the UK for further care. Subsequently, she underwent an ablation procedure, which involves creating scar tissue to disrupt the faulty electrical pathways causing the abnormal rhythm. She has reported stable health since the operation.
Reflecting on her ordeal, Williams emphasized the remarkable resilience of the human body but also acknowledged the anxiety that cardiovascular problems can provoke. She highlighted the critical role of the British Heart Foundation, the UK’s leading independent funder of heart research, which invests approximately £100 million annually into studies aimed at understanding and combating heart disease.
Among the advancements supported by the BHF is the work of Professor Charalambos Antoniades, who has developed an artificial intelligence tool capable of predicting an individual’s risk of heart attack up to a decade in advance. This innovation could allow for early intervention and preventive care. Additionally, the foundation backs research into gene therapies that may prevent, treat, or even reverse damage caused by heart attacks, in partnership with the Medical Research Council.
Cardiovascular disease remains a leading cause of death in the UK, claiming a life every three minutes. Williams’s experience has led her to advocate for increased public support for heart research, urging donations to sustain efforts aimed at reducing the burden of heart disease. The British Heart Foundation continues to seek funding to advance lifesaving treatments and improve outcomes for those affected.